Using artificial intelligence (AI) to diagnose scans for heart disease and lung cancer could save the NHS billions of pounds, according to life sciences tsar, Sir John Bell.
Abbott's new glucose monitoring device could be used by millions of diabetes patients in the US after government-funded health schemes agreed to pay for it.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
